Samir Mitragotri

Active 1995–2025

247
Papers
59,588
Citations
124
h-index
240
i10-index

Citations

Citations per year for Samir Mitragotri1995: 2 citations1996: 8 citations1997: 11 citations1998: 7 citations1999: 13 citations2000: 51 citations2001: 45 citations2002: 72 citations2003: 76 citations2004: 133 citations2005: 81 citations2006: 136 citations2007: 150 citations2008: 189 citations2009: 238 citations2010: 274 citations2011: 324 citations2012: 387 citations2013: 391 citations2014: 470 citations2015: 559 citations2016: 523 citations2017: 657 citations2018: 606 citations2019: 1,797 citations2020: 2,416 citations2021: 2,657 citations2022: 2,451 citations2023: 2,199 citations2024: 3,244 citations2025: 1,597 citations2026: 52 citations

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,312 citing papers, 20.7% of this breakdownUnited States: 4,258 citing papers, 20.4% of this breakdownIndia: 1,166 citing papers, 5.6% of this breakdownUnited Kingdom: 865 citing papers, 4.2% of this breakdownSouth Korea: 653 citing papers, 3.1% of this breakdownGermany: 620 citing papers, 3% of this breakdownAustralia: 567 citing papers, 2.7% of this breakdownItaly: 544 citing papers, 2.6% of this breakdownIran: 450 citing papers, 2.2% of this breakdownCanada: 414 citing papers, 2% of this breakdownSpain: 408 citing papers, 2% of this breakdownFrance: 389 citing papers, 1.9% of this breakdown
0%20.7%Other 29.6%

Fields

  • Biochemistry, Genetics and Molecular Biology21.4%
  • Medicine18.3%
  • Materials Science17.4%
  • Pharmacology, Toxicology and Pharmaceutics15.7%
  • Engineering12.9%
  • Immunology and Microbiology6.3%
  • Other8%

Topics

  • Nanoparticle-Based Drug Delivery7.3%
  • RNA Interference and Gene Delivery5.8%
  • Advanced Drug Delivery Systems5.1%
  • Nanoplatforms for cancer theranostics4.5%
  • Advancements in Transdermal Drug Delivery4.5%
  • Advanced biosensing and bioanalysis techniques3%
  • Other69.8%

Coauthors

All papers

Open in search
  1. The evolution of commercial drug delivery technologies

    Authors: , , - Nature Biomedical Engineering 2021 cited by 1,297

  2. Targeting Strategies for Tissue-Specific Drug Delivery

    Authors: , , , - Cell 2020 cited by 1,080

  3. Nanoparticles in the clinic: An update

    Authors: , - Bioengineering & Translational Medicine 2019 cited by 1,661

  4. Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects

    Authors: , - Nano Today 2014 cited by 1,242

  5. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

    Authors: , , - Nature Reviews Drug Discovery 2014 cited by 1,643

  6. Hydrogels in the clinic

    Authors: , , , - Bioengineering & Translational Medicine 2020 cited by 475

  7. Materials for oral delivery of proteins and peptides

    Authors: , , - Nature Reviews Materials 2019 cited by 501

  8. Strategies to improve the EPR effect: A mechanistic perspective and clinical translation

    Authors: , , , , , - Journal of Controlled Release 2022 cited by 295

  9. Non-invasive delivery strategies for biologics

    Authors: , , - Nature Reviews Drug Discovery 2018 cited by 632

  10. Cellular backpacks for macrophage immunotherapy

    Authors: , , , , , , , , , , - Science Advances 2020 cited by 405

  11. Role of nanoparticle size, shape and surface chemistry in oral drug delivery

    Authors: , , , , - Journal of Controlled Release 2016 cited by 750

  12. PEGylated therapeutics in the clinic

    Authors: , , , - Bioengineering & Translational Medicine 2023 cited by 201

  13. Nanoparticles in the clinic

    Authors: , - Bioengineering & Translational Medicine 2016 cited by 1,257

  14. Viral vector‐based gene therapies in the clinic

    Authors: , , - Bioengineering & Translational Medicine 2021 cited by 251

  15. Covalently Crosslinked Hydrogels via Step‐Growth Reactions: Crosslinking Chemistries, Polymers, and Clinical Impact

    Authors: , , - Advanced Materials 2021 cited by 274

  16. Current status and future potential of transdermal drug delivery

    Authors: , , - Nature Reviews Drug Discovery 2004 cited by 1,453

  17. Role of target geometry in phagocytosis

    Authors: , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 2,049

  18. Elasticity of Nanoparticles Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting

    Authors: , , , , , , - ACS Nano 2015 cited by 631

  19. Bio-inspired, bioengineered and biomimetic drug delivery carriers

    Authors: , , , - Nature Reviews Drug Discovery 2011 cited by 1,221

  20. Nanoparticles in the clinic: An update post COVID‐19 vaccines

    Authors: , - Bioengineering & Translational Medicine 2021 cited by 310

  21. Alzheimer's and Parkinson's disease therapies in the clinic

    Authors: , , , , , - Bioengineering & Translational Medicine 2022 cited by 165

  22. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 351

  23. Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow

    Authors: , , , , - Bioengineering & Translational Medicine 2019 cited by 202

  24. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers

    Authors: , , , - Advanced Drug Delivery Reviews 2019 cited by 430